Member Info for equitrder

Don't think u can chat about US equities on this forum!!

Shrew... Every heard of a tax write off? The IRS keeps and eye on you wherever you are. Naive hardly,I'm just wondering why I haven't seen many large investors gobble up shares if this stock is such a cert. Not a question a Statement! Has Harry Stratford invested I'm sure he is a rich man or is he waiting on options. I notice Providence Resources new chairman invested 120 grand in his new company.

I called a pump and dump 2 months ago when the stock was trading at .21 and was lambasted. This is the slow walk down on tiny volume. Funny how we have not heard from earlybird in ages!!!

Oh my bad Over 2.6 billion?

SAR have very few shares outstanding. Very easy to manipulate!

Isn't AP102 just going into Phase 1? So any news is basically redundant at this stage. as for Episalvan's approval for EB I think we won't find out until 3rd quarter. Just my 2 cents

The only news they can update us on is Imlan.. We won't get the results on trials until this time next year..

2 bites with a hell of a lot of risk might I add. I'm only here because of management HOPING they can execute.

Imo Birken are sufficiently manpowered to produce the product needed for trial purposes,afterall the have the facilities to produce Imlan. Now Imlan is not necessary part of their business plan so I'd say they will want to partner with one of the better skincare companies(can't sell because I think Imlan is Episalvan LIGHT (low dosage))) I don't think they plan to be a real pharma company I think they plan to sell on FDA approval and maybe keep the Som pharma subsidery until it gets its approval. IMO Som pharma is where the big money is and could take longer to get approval but will need alot more cash. So I'm hoping we get 2 bites.

I read somewhere that there is some partnership with the University of California. It's might be Som can't find it now

Yeah it'll be this time next year before we know anything about the trial

Wishing and hoping.. Cathal did mention that in one of the shareholder meetings. We will see as of now the market values us at about 40 mil,based on their comparisons within the sector management have aspirations of 600 mil. Definately a nice return if all goes to plan

Aegerion hasn't set the world alight..but he can't do the CEO's job.Stock has dropped from 90 to 1.70 It's basically the same size as Amryt now Notice he is based in Switzerland where Som pharmaceutical is..

Well imho after a quick look at Amicus (FOLD) the buyer of Scioderm 'THEY OVERPAID' Before the buyout they were trading at over 17 now at 7 Market cap 960 mil now

Nope AIM is the same as the Pink Sheets (OTC)over in America.. Boiler room stuff..

Yep thats technical,I'm thinking you would need to go to a shareholder meeting to get that answered. Maybe Early Bird could ask Cathal,I wouldnt consider that insider information..

Olderandwiser,we got it you own IMM.. Yes the AIM stock exchange is like the wild west but you must remember these stocks are start-ups with no revenue. Most will fail.! The advantage that Amryt has (I hope) is the strong management team.

I should say crazy paperwork involved and lots of research... I know there is 1 company out there with a similar product but the dressings have to be changed more than once a day. Are there more??

Actually i know this industry was involved in.patenting medical devices for animal welfare. Never had any issues.

Wondering why there was opposition to the granting of a patent in the US?